Evidence map›Paper›PMID 19524633›Full record

ArticleHuman immunology2009

Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice.

Christin M Lepus, Thomas F Gibson, Scott A Gerber, Ivana Kawikova, Marian Szczepanik, Jaber Hossain, Vitaly Ablamunits, Nancy Kirkiles-Smith, Kevan C Herold, Ruben O Donis and 3 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Human immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 127 citations in OpenAlex.

  1. Humanized immune system animal models and their recent applications.Animal models and experimental medicine · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Humanized mice enableMolecular therapy. Advances · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Fetal liver CD34Stem cell research & therapy · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Humanized mouse models for immuno-oncology research.Nature reviews. Clinical oncology · 2023
    Review
  18. Article
  19. Article
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Christin M LepusSection of Comparative Medicine, Yale University School of Medicine, New Haven, CT 06509, USA.
Thomas F Gibson
Scott A Gerber
Ivana Kawikova
Marian Szczepanik
Jaber Hossain
Vitaly Ablamunits
Nancy Kirkiles-Smith
Kevan C Herold
Ruben O Donis
Alfred L Bothwell
Jordan S Pober
Martha J Harding
Yale University · USCenters for Disease Control and Prevention · USJagiellonian University · PL

Funding

SOCS-1 and endothelial dysfunction in graft arteriosclerosisP01HL070295 · NHLBI · YALE UNIVERSITY · PI SESSA, WILLIAM C · 2001 to 2010
$17.9M
NHLBI NIH HHS P01 HL070295NHLBI NIH HHS P01-HL070295NIDDK NIH HHS DK0724429
6 · The paper itself

Abstract

Immunodeficient mice bearing components of a human immune system present a novel approach for studying human immune responses. We investigated the number, phenotype, developmental kinetics, and function of developing human immune cells following transfer of CD34(+) hematopoietic stem cell (HSC) preparations originating from second trimester human fetal liver (HFL), umbilical cord blood (UCB), or granulocyte colony-stimulating factor-mobilized adult blood (G-CSF-AB) delivered via intrahepatic injection into sublethally irradiated neonatal NOD-scid/gammac(-/-), Balb/c-Rag1(-/-)gammac(-/-), and C.B-17-scid/bg mice. HFL and UCB HSC provided the greatest number and breadth of developing cells. NOD-scid/gammac(-/-) and Balb/c-Rag1(-/-)gammac(-/-) harbored human B and dendritic cells as well as human platelets in peripheral blood, whereas NOD-scid/gammac(-/-) mice harbored higher levels of human T cells. NOD-scid/gammac(-/-) mice engrafted with HFL CD34(+) HSC demonstrated human immunological competence evidenced by white pulp expansion and increases in total human immunoglobulin following immunization with T-dependent antigens and delayed-type hypersensitivity-infiltrating leukocytes in response to antigenic challenge. In conclusion, we describe an encouraging base system for studying human hematopoietic lineage development and function utilizing human HFL or UCB HSC-engrafted NOD-scid/gammac(-/-) mice that is well suited for future studies toward the development of a fully competent humanized mouse model.

Indexed as

AnimalsFetal BloodGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell MobilizationHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHemocyaninsHumansHypersensitivity, DelayedImmunoglobulinsInfluenza A Virus, H5N1 SubtypeLiverLymph NodesLymphocyte SubsetsMiceMice, Inbred BALB CGranulocyte Colony-Stimulating FactorHemocyaninsImmunoglobulinskeyhole-limpet hemocyanin

Identifiers

PMID19524633
PMCPMC2949440
OpenAlexW2042523031

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.